Area of research
Molecular Biology · Dermatology
Research interest
Research interests include Hedgehog Signaling Pathway Studies, Cancer and Skin Lesions, Nonmelanoma Skin Cancer Studies, and Skin and Cellular Biology Research.
Sephardic origins revealed for rare skin disorder, recessive dystrophic epidermolysis bullosa, in individuals carrying the unique c.6527insC mutation
CCL2-mediated endothelial injury drives cardiac dysfunction in long COVID
A scalable and cGMP-compatible autologous organotypic cell therapy for Dystrophic Epidermolysis Bullosa
428 Functional genotype classification groups distinguish disease severity in recessive dystrophic epidermolysis bullosa
Integrated single-cell chromatin and transcriptomic analyses of human scalp identify gene-regulatory programs and critical cell types for hair and skin diseases
The HHIP-AS1 lncRNA promotes tumorigenicity through stabilization of dynein complex 1 in human SHH-driven tumors
Analysis of Whole Genome Sequencing in a Cohort of Individuals with PHACE Syndrome Suggests Dysregulation of RAS/PI3K Signaling
Retinoic acid and BMP4 cooperate with p63 to alter chromatin dynamics during surface epithelial commitment
MTSS1/Src family kinase dysregulation underlies multiple inherited ataxias
456 Pilot study of topical itraconazole for the treatment of basal cell carcinomas in gorlin syndrome patients
179 Drug resistance in basal cell carcinoma identifies the inner nuclear membrane as a critical GLI1 regulatory checkpoint
1435 Dynamic morphogen-p63 chromatin interactions that guide epigenetic changes and p63 activity in surface ectoderm commitment
225 Characterizing the accessible chromatin landscape of resistant basal cell carcinoma
210 MRTF inhibition displays promising therapeutic potential in human BCC patient explants
RAS/MAPK Activation Drives Resistance to Smo Inhibition, Metastasis, and Tumor Evolution in Shh Pathway–Dependent Tumors
Somatic Correction of Junctional Epidermolysis Bullosa by a Highly Recombinogenic AAV Variant
Augmenting Endogenous Wnt Signaling Improves Skin Wound Healing
Efficacy and Safety of Vismodegib in Advanced Basal-Cell Carcinoma